US 8951964
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
granted A61PA61P31/12
Quick answer
US patent 8951964 (Phenanthridine macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/12